Mild cognitive impairment: clinical characterization and outcome
about
Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trialsPlasmatic level of neurosin predicts outcome of mild cognitive impairment.Lifestyle-related factors in predementia and dementia syndromesMultiple cognitive deficits during the transition to Alzheimer's diseaseAutomated MRI measures identify individuals with mild cognitive impairment and Alzheimer's diseaseLanguage performance in Alzheimer's disease and mild cognitive impairment: A comparative reviewWestern diet consumption and cognitive impairment: links to hippocampal dysfunction and obesityNeural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patientsNeuropsychological features of mild cognitive impairment and preclinical Alzheimer's diseaseInstrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?Amyloid-associated depression: a prodromal depression of Alzheimer disease?Distinguishing Between Depression and Dementia in Older Persons: Neuropsychological and Neuropathological CorrelatesCumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone leadSubjective Memory Complaints and Cognitive Impairment in Older People18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Dietary interventions for maintaining cognitive function in cognitively healthy people in late lifeDietary interventions for prevention of dementia in people with mild cognitive impairmentDietary interventions for maintaining cognitive function in cognitively healthy people in mid lifeVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid lifeVitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in late lifeVitamin and mineral supplementation for prevention of dementia or delaying cognitive decline in people with mild cognitive impairmentCognitive training interventions for dementia and mild cognitive impairment in Parkinson’s DiseaseExercise interventions for preventing dementia or delaying cognitive decline in people with mild cognitive impairmentExercise interventions for maintaining cognitive function in cognitively healthy people in mid lifeIntravenous immunoglobulin for Alzheimer's diseaseExercise interventions for maintaining cognitive function in cognitively healthy people in late lifeSouvenaid for Alzheimer's diseasePlasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)Passive immunisation with monoclonal anti-Abeta antibodies for the treatment of Alzheimer's diseaseNeuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesCholinesterase inhibitors for mild cognitive impairment11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Psychological treatments for depression and anxiety in dementia and mild cognitive impairmentThe accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCIHuperzine A for mild cognitive impairmentThe role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)Huperzine A for mild cognitive impairment
P2860
Q21092367-E3CAA047-CC08-4A66-9939-D0325703AE1AQ21202048-6D68848A-CAAB-4BC5-81C0-B9449576A1C0Q22241490-9E14535A-E8DF-41D5-A2BC-232B2144BAFDQ22242620-A8DE2EEF-44D2-4785-BDF9-CDC6C853EAAAQ22242926-55B59363-27EA-44B8-BF33-EB08D0F51E75Q22248003-461F924B-D83B-4B12-83B5-7754EC27D442Q22251221-81A5C4EB-E872-46C8-A057-A9D0EE3C441BQ22251259-33BC70D6-B9CF-402F-8F09-481D45B30153Q22251334-F52617CC-AB7F-4A3F-B1B8-0E8B8B40F507Q22251335-27C12B8B-A195-4218-9734-853FD5A7BE70Q22253023-DE4C8087-6797-42DA-A293-40CB15E97809Q22299260-E14F1690-F1F2-4181-9CE9-AD6ABDB147C1Q22306124-E7B8111B-3637-4475-8930-D64B36E727A7Q22306419-E1E30FA0-3753-4DEE-AE6E-3B194A553955Q24186399-01C8AAAA-2692-4AAF-9424-BA22D33703A8Q24186820-CB7DDFBF-85F9-4B4C-9F0B-D5E36F2A8C91Q24186832-B33BF72D-21F7-4A67-B5E2-20BC8E042EA9Q24186838-E5B98F79-17B5-4252-9A79-4E70ACA0B63BQ24186855-606EC543-B2EF-4F44-BCD4-F08757A6E0F9Q24186867-4E011A17-C499-485D-BAF7-52050189BB1FQ24186872-90847851-CEAE-43CB-8A8C-574568A5AF68Q24188194-FF253795-737E-4D4E-9F6C-4AF78CD9525DQ24188208-9E855091-D257-48DD-9414-43E77403858FQ24188214-97F5632B-3AA8-4B3C-9768-3333F55801EDQ24188215-B744C064-9902-4082-9901-6E56D8F7C8E0Q24188220-7E53C06D-7D48-4931-8B24-19931B566CDBQ24188326-A37107E0-B2E8-4A54-949A-E2D36234B2B0Q24193707-62417C2B-CCE8-4A86-9AC1-D0D19421DD2BQ24194742-41EF10D8-72E3-40D1-95A0-7CA8ADF7074DQ24197654-DD757885-23C9-4474-B0BB-588B00558110Q24197659-0C55C160-D361-4F11-A5C5-58A8E63B7B60Q24197852-C2C8ED37-8946-40A1-9FFD-0F70C572D2A3Q24200257-F3B5622E-9FFB-404F-B55D-CF734725DCE9Q24200430-64092D3B-C5B8-4445-9150-03B2DD1F6C50Q24201039-4C01FA8A-C151-4B37-BD4D-236D0206E78FQ24201053-4582F5EF-F77C-47A5-A0EC-B0FFADF79AE3Q24201440-AA4521B8-F34A-4E74-8581-E44188F8A7A4Q24202101-A98E0666-D92E-4D02-B6EA-C4BF6AA548CCQ24203748-5C409554-237E-4A09-9441-784D70D12006Q24234330-9479F508-8D0D-4FEE-8381-C941AD7E9AB0
P2860
Mild cognitive impairment: clinical characterization and outcome
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mild cognitive impairment: clinical characterization and outcome
@ast
Mild cognitive impairment: clinical characterization and outcome
@en
Mild cognitive impairment: clinical characterization and outcome
@nl
type
label
Mild cognitive impairment: clinical characterization and outcome
@ast
Mild cognitive impairment: clinical characterization and outcome
@en
Mild cognitive impairment: clinical characterization and outcome
@nl
altLabel
Mild Cognitive Impairment
@en
prefLabel
Mild cognitive impairment: clinical characterization and outcome
@ast
Mild cognitive impairment: clinical characterization and outcome
@en
Mild cognitive impairment: clinical characterization and outcome
@nl
P2093
P3181
P1433
P1476
Mild cognitive impairment: clinical characterization and outcome
@en
P2093
E G Tangalos
R C Petersen
S C Waring
P3181
P356
10.1001/ARCHNEUR.56.3.303
P407
P577
1999-03-01T00:00:00Z